Abstract
This is a literature review of 31 case series of endogenous endophthalmitis (EE) published in the last ten years, identified from a literature search of several databases (PubMed, EMBASE, and the Cochrane Library). While diabetes mellitus and malignancies remain the most frequently associated medical conditions, intravenous drug use is a significant risk factor (especially in the last years, in studies from Western countries). Ophthalmologic screening is recommended for candidaemia, but not in patients with sepsis of other aetiologies (however, the physician treating patients with sepsis must be well aware of EE). The most frequent Gram-positive microorganisms that cause EE are Staphylococcus and Streptococcus; the most frequent Gram-negative organism is Pseudomonas, and yeasts, probably Candida, usually cause fungal infections. In all-cause EE, prognostic factors of better visual outcomes are initial VA better than counting fingers, performing a pars plana vitrectomy (PPV), performing an intravitreal injection within the first 24 hours after clinical diagnosis, and the presence of a focal type of EE. In endogenous fungal endophthalmitis, more than 1/4 of patients have bilateral involvement. Blood samples have a low rate of positivity. Yeasts remain the most prevalent cause. Many authors report using azoles and echinocandins for systemic therapy (and voriconazole for intravitreal injections). Although PPV was performed in small proportions of eyes, the anatomical success rate is quite high. Klebsiella pneumoniae is an important cause of EE in Southeast Asia (and probably an emergent etiology in other regions), which is frequently associated with diabetes. There is a robust association with pyogenic liver abscess (PLA) (but in up to half of the cases, the diagnosis of EE precedes that of PLA). Blood cultures have a high diagnostic yield, while vitreous samples have a low yield. K. pneumoniae may carry antibiotic resistance. Anatomical and functional success rates are small, but they may be improved with PPV.
Highlights
Endogenous endophthalmitis (EE) is an intraocular infection caused by hematogenous spread from distant foci
In a large retrospective cross-sectional study on 258092 patients with hematogenous infections and 3704 with fungemia, found an EE incidence rate of 0.05% [59]. ey have found that leading predictors included infectious meningitis, endocarditis, and abscesses; comorbidities indicative of immunodeficiency; intensive care unit admission; and longer hospital stays. ese patient characteristics can help predict patients’ risk of developing endogenous endophthalmitis
Recent studies of isolates from endophthalmitis patients found that bacteria in EE cases were most susceptible to levofloxacin, ceftazidime, and cefazolin [78, 79]
Summary
Endogenous endophthalmitis (EE) is an intraocular infection caused by hematogenous spread from distant foci. It is an uncommon but visual severe loss cause that may have devastating ocular and systemic complications [1]. Collaboration with a medical team (including intensive care and infectious disease specialists) is mandatory. In some cases, it is associated with septicemia and, unlike most ocular inflammations, may have a significant mortality rate. Our rationale was that case reports tend to be published if they are unusual, but case series provide valuable insight into ophthalmology departments’ real-life experience
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
